Evidence map›Paper›PMID 39273262›Full record

ArticleInternational journal of molecular sciences2024

Effect of Levetiracetam on Oxidant-Antioxidant Activity during Long-Term Temporal Lobe Epilepsy in Rats.

Iván Ignacio-Mejía, Itzel Jatziri Contreras-García, Luz Adriana Pichardo-Macías, Mercedes Edna García-Cruz, Blanca Alcira Ramírez Mendiola, Cindy Bandala, Omar Noel Medina-Campos, José Pedraza-Chaverri, Noemí Cárdenas-Rodríguez, Julieta Griselda Mendoza-Torreblanca

Abstract read
In one paragraph

Article in International journal of molecular sciences, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

2 citing papers in PubMed.

  1. Review
  2. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors.

Iván Ignacio-MejíaLaboratorio de Medicina Traslacional, Escuela Militar de Graduados de Sanidad, UDEFA, Mexico City 11200, Mexico.ORCID 0000-0003-3792-4613
Itzel Jatziri Contreras-GarcíaLaboratorio de Medicina Traslacional, Escuela Militar de Graduados de Sanidad, UDEFA, Mexico City 11200, Mexico.
Luz Adriana Pichardo-MacíasDepartamento de Fisiología, Instituto Politécnico Nacional, Escuela Nacional de Ciencias Biológicas, Mexico City 07738, Mexico.
Mercedes Edna García-CruzLaboratorio de Neurociencias, Instituto Nacional de Pediatría, Secretaría de Salud, Mexico City 04530, Mexico.
Blanca Alcira Ramírez MendiolaLaboratorio de Farmacología, Instituto Nacional de Pediatría, Secretaría de Salud, Mexico City 04530, Mexico.
Cindy BandalaLaboratorio de Neurociencia Traslacional Enfermedades Crónicas y Emergentes, Escuela Superior de Medicina, Instituto Politécnico Nacional, Mexico City 11410, Mexico.ORCID 0000-0002-7414-2621
Omar Noel Medina-CamposDepartamento de Biología, Facultad de Química, Universidad Nacional Autónoma de México, Mexico City 04510, Mexico.ORCID 0000-0001-8264-0412
José Pedraza-ChaverriDepartamento de Biología, Facultad de Química, Universidad Nacional Autónoma de México, Mexico City 04510, Mexico.ORCID 0000-0001-6628-4411
Noemí Cárdenas-RodríguezLaboratorio de Neurociencias, Instituto Nacional de Pediatría, Secretaría de Salud, Mexico City 04530, Mexico.ORCID 0000-0002-6580-3440
Julieta Griselda Mendoza-TorreblancaLaboratorio de Neurociencias, Instituto Nacional de Pediatría, Secretaría de Salud, Mexico City 04530, Mexico.ORCID 0000-0003-0702-5318

Funding

Instituto Nacional de Pediatria 2022/048
6 · The paper itself

Abstract

Epilepsy is a disorder characterized by a predisposition to generate seizures. Levetiracetam (LEV) is an antiseizure drug that has demonstrated oxidant-antioxidant effects during the early stages of epilepsy in several animal models. However, the effect of LEV on oxidant-antioxidant activity during long-term epilepsy has not been studied. Therefore, the objective of the present study was to determine the effects of LEV on the concentrations of five antioxidant enzymes and on the levels of four oxidant stress markers in the hippocampus of rats with temporal lobe epilepsy at 5.7 months after status epilepticus (SE). The results revealed that superoxide dismutase (SOD) activity was significantly greater in the epileptic group (EPI) than in the control (CTRL), CTRL + LEV and EPI + LEV groups. No significant differences were found among the groups' oxidant markers. However, the ratios of SOD/hydrogen peroxide (H

Indexed as

AntioxidantsCatalaseEpilepsy, Temporal LobeGlutathione PeroxidaseLevetiracetamOxidative StressSuperoxide DismutaseAnimalsAnticonvulsantsDisease Models, AnimalHippocampusHydrogen PeroxideMaleOxidantsRatsRats, WistarAnticonvulsantsAntioxidantsCatalaseGlutathione PeroxidaseHydrogen PeroxideLevetiracetamOxidantsSuperoxide Dismutaseantioxidant enzymeslevetiracetamlong-term epilepsyoxidant markersoxidative stresstemporal lobe epilepsy

Identifiers

PMID39273262
PMCPMC11395009

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.